FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/08/2026
Voltar para busca
Dado oficial do USPTO
KADMOS BIOTECH
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
KADMOS BIOTECH
ST13
US500000079410821Classe
1, 5, 10, 42, 44
Pedido
79410821
Registro
8122471
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
27
Atualização mais recente
10/08/2026
Tipo de marca
Verbal
Classes Nice
1, 5, 10, 42, 44
Data de depósito
27/05/2024
Data de registro
03/02/2026
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
03/02/2026
Última transação
10/08/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
16
Localização do titular
DE
Examinador
NOVAKOVIC, MIROSLAV
Unidade examinadora
L80
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Kadmos Biotech GmbH
Representantes
Mark P. Stone Law Office of Mark P. Stone
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical substanceschemical materials and chemical preparations and biological materialshuman stem cells and iPSC-derived cells and extracellular matrix which can be comprised of proteinspeptidespolysaccharidesamino acidslipidsenzymesgrowth factors and biopolymersfor use in the field of oral medical therapy or for research purposesin particularfor dental and jaw restoration purposes; stem cells for research purposes; stem cells for scientific purposes.
Classe 5
Medical and veterinary preparations for use in the field of oral medical therapy for dental and jaw restoration purposes; stem cells for medical purposes; medicated dental care preparations for the treatment of periodontal diseases and for promoting oral tissue regeneration; dental filling materialsdental cements.
Classe 10
Medical and veterinary apparatus and instruments for use in the field of oral medical therapy for dental and jaw restoration purposes; apparatus for the regeneration of stem cells for medical purposes; dental prostheses; artificial jaws; dental implants being prosthesis made of artificial materials for use in dentistry; dental implants being prosthesis made of artificial materials for use in jawbone surgery; dental implants and prostheticscell-based and tissue-engineeerd implants composed of biologicalbiocompatible or composite materials for use in dental and jawbone regeneration.
Classe 42
Science and technology servicesscientific research in the fields of oral medical therapydental and jaw restorationregenerative medicine; medical and pharmacological research services; research in the field of dental biomechanics; stem cell research services; product research and development in the field of oral medical therapy for dental and jaw restoration purposes.
Classe 44
Medical services relating to the removaltreatment and processing of stem cells; stem cell storagestem cell bank services; regenerative dentistry services; advice relating to dentistry; oral surgery services; orthodontic services.
Publicações
Histórico de despachos e eventos da marca no USPTO.
27 publicações encontradas
FIMP
FINAL DISPOSITION PROCESSED
10/08/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
14/05/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/05/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
27/04/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
27/04/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/02/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
03/02/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
16/12/2025
PUBO
PUBLISHED FOR OPPOSITION
16/12/2025
GPNX
NOTIFICATION PROCESSED BY IB
11/12/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/12/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
26/11/2025
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
25/11/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
15/11/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/11/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/11/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/11/2025
RFNT
REFUSAL PROCESSED BY IB
27/09/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/09/2025
RFRR
REFUSAL PROCESSED BY MPU
06/09/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
31/07/2025
CNRT
NON-FINAL ACTION WRITTEN
30/07/2025
DOCK
ASSIGNED TO EXAMINER
30/07/2025
MAFR
APPLICATION FILING RECEIPT MAILED
29/07/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
29/07/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
28/11/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace KADMOS BIOTECH ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.